Condition
Recurrent Transformed Non-Hodgkin Lymphoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Recurrent Transformed Non-Hodgkin Lymphoma clinical trials that are recruiting, in United States. By phase: Phase 2 (2), Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest Recurrent Transformed Non-Hodgkin Lymphoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Using golcadomide and rituximab to prepare patients for CAR T-cell therapy in aggressive B-cell lymphoma | Phase 2 | Scottsdale, Arizona and 6 other locations | Recruiting | Feb 19, 2025 |
| Combination treatment of epcoritamab and ibrutinib for aggressive B-cell lymphoma | Phase 1/2 | Minneapolis, Minnesota and 2 other locations | Recruiting | Aug 2, 2024 |
| Combining zanubrutinib and CAR T-cell therapy for treating Richter's syndrome | Phase 2 | New York, New York and 2 other locations | Recruiting | May 24, 2023 |
| Using genetically modified T-cells and a vaccine to treat certain types of B-cell lymphoma after stem cell transplantation | Phase 1 | Duarte, California | Recruiting | Jun 27, 2022 |
All recruiting trials (4)
-
Using golcadomide and rituximab to prepare patients for CAR T-cell therapy in aggressive B-cell lymphoma
This study is testing if a combination of golcadomide and rituximab can help patients with aggressive B-cell lymphoma get ready for CAR T-cell therapy.
-
Combination treatment of epcoritamab and ibrutinib for aggressive B-cell lymphoma
This study is testing a new combination of two treatments, epcoritamab and ibrutinib, to see if they can help people with aggressive B-cell lymphoma that hasn't responded to other therapies.
-
Combining zanubrutinib and CAR T-cell therapy for treating Richter's syndrome
This study is testing if combining zanubrutinib with CAR T-cell therapy can help people with Richter's syndrome, which is when chronic lymphocytic leukemia turns into a more aggressive lymphoma.
-
Using genetically modified T-cells and a vaccine to treat certain types of B-cell lymphoma after stem cell transplantation
This study is testing a new treatment using specially modified immune cells and a vaccine to see if it can help people with certain types of B-cell lymphoma after they've had a stem cell transplant.
Related topics
Quick answers
How many Recurrent Transformed Non-Hodgkin Lymphoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.